25 February 2023 (01:24-UTC-07 Tango 06) 06 Esfand 1401/04 Sha’ban 1444/06 Jia-Yin(2nd month) 4721/25 февраля 2023 года

The U.S. Food and Drug Administration (FDA) issued a warning about Pfizer’s RSV (Respiratory Syncytial Virus) vaccine; risk of neurological Gullain-Barré Syndrome (GBS) and its variant Miller Fisher Syndrome (MFS)!

During the trials for Pfizer’s RSV vaccine at least two people developed GBA, and one other person developed MFS within eight days after vaccination.

You can find the details on page six of the FDA’s PDF document: Vaccines and Related Biological Products Advisory Committee Meeting February 28, 2023.  The document also lists adverse reactions.

Pfizer/BioNTech is also applying for full U.S. approval of yet another CoViD vaccine.  This time it is for their Omicron bivalent version, which is already ‘authorized’ in the European Union.

Trials violations forced Pfizer to halt testing of a new Lyme Disease vaccine, in Massachusetts! Trials were being conducted by a contractor in Nantucket and Martha’s Vineyard, due to the high prevalence of Lyme Disease, but after a whistleblower revealed violations of the FDA’s GCP (Good Clinical Practice) rules Pfizer decided to investigate the contractor: “Once Pfizer learned of potential violations of GCP, it conducted a thorough review of the operations and data collection at the clinical trial sites run by the third party and followed standard operating safeguards to determine the correct course of action.”–17FEB2023 Pfizer statement

On top of that, Pfizer has fired its Lyme Disease vaccine trials contractor, Care Access!

In California, more than 1-hundred Pfizer employees losing their jobs!  Pfizer notified state unemployment officials that it is shutting down its San Diego-Torrey Pines research and development center, the layoffs will be ongoing until June 2023. Pfizer admits the decision is about which new drugs can make the most profit: “…we have made the very difficult decision to discontinue some research projects to focus on programs where our innovation and investments may be best positioned to deliver high-impact breakthrough medicines and vaccines.”

And lastly, apparently Pfizer admits that its Breakthrough Fellowship Program has discriminated against Asians and ‘whites’!  Pfizer is changing its policy regarding the program after threats of a lawsuit in federal court, because, until now, the program openly advertised for Black/African American, Latino/Hispanic and Native Americans, only!  The fellowship program promises applicants that they will end up with a Masters Degree and employment with Pfizer.

Vaccine Fail: MODERNA’S NEW SHOT FAILS TRIAL! PFIZER’S NEW SHOT FAILS DUE TO GCP VIOLATIONS!

REVEALED, INCREDIBLY MASSIVE SPIKE IN ADVERSE REACTIONS DURING MONTHS FOLLOWING m-R-N-A INJECTIONS!